NCI vs AS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

NCI

43.6
AI Score
VS
AS Wins

AS

52.9
AI Score

Investment Advisor Scores

NCI

44score
Recommendation
HOLD

AS

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NCI AS Winner
Forward P/E 0 14.5773 Tie
PEG Ratio 1.13 0.4389 AS
Revenue Growth -50.8% 32.1% AS
Earnings Growth 34.0% 500.0% AS
Tradestie Score 43.6/100 52.9/100 AS
Profit Margin 0.2% 7.3% AS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NCI 1M: -94.6% · 3M: -93.4% AS 1M: +5.5% · 3M: -19.7%

Current Technical Phase

NCI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -34.7%), weak momentum, RSI 18

RSI (14): 17.6 · Price: $0.79

AS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -8.7%) with fading momentum, RSI 46

RSI (14): 45.5 · Price: $28.24

Fundamentals Snapshot

Metric NCI AS
Market Cap — —
Forward P/E 0.0 24.1
Trailing P/E 9.0 31.2
Revenue (TTM) — —
Revenue Growth -0.5% 0.3%
Gross Margin 0.4% 0.6%
Operating Margin 0.0% 0.1%
EPS 0.08 0.93
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.